Mayana Zatz Selected Research

myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)

1/2021	Inositol monophosphatase 1 (IMPA1) mutation in intellectual disability patients impairs neurogenesis but not gliogenesis.
1/2019	Loss-of-function mutation in inositol monophosphatase 1 (IMPA1) results in abnormal synchrony in resting-state EEG.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mayana Zatz Research Topics

Disease

11	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2017 - 04/2007
11	Muscular Dystrophies (Muscular Dystrophy) 01/2017 - 12/2003
7	COVID-19 01/2022 - 01/2021
5	Neoplasms (Cancer) 01/2022 - 02/2015
5	Pneumonia (Pneumonitis) 01/2022 - 01/2015
5	Inflammation (Inflammations) 10/2021 - 02/2013
5	Disease Progression 01/2017 - 12/2002
4	Infections 01/2022 - 01/2020
4	Fibrosis (Cirrhosis) 01/2017 - 02/2013
4	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 08/2014 - 09/2003
4	Alzheimer Disease (Alzheimer's Disease) 01/2010 - 01/2004
3	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 08/2021 - 01/2003
3	Intellectual Disability (Idiocy) 01/2021 - 01/2019
3	Central Core Myopathy (Central Core Disease) 12/2020 - 05/2007
3	Atrophy 01/2019 - 01/2003
3	Muscle Weakness 05/2015 - 01/2003
3	Type 2I Limb-Girdle Muscular Dystrophy 11/2008 - 12/2003
2	Inborn Genetic Diseases (Disease, Hereditary) 11/2021 - 07/2016
2	Myotonia Congenita (Thomsen Disease) 11/2021 - 03/2010
2	Wounds and Injuries (Trauma) 02/2021 - 01/2021
2	Fasciculation (Fasciculations) 01/2019 - 01/2003
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2015 - 01/2015
2	Type 1C Limb-Girdle Muscular Dystrophy 08/2014 - 12/2003
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2013 - 07/2007
2	Alcoholism (Alcohol Abuse) 06/2005 - 05/2005
1	Reinfection 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Hyperplasia 01/2022
1	Rare Diseases (Rare Disease) 10/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Obesity 01/2021
1	Shock 01/2021
1	Asymptomatic Infections 01/2021
1	Malaria 06/2020
1	Muscle Spasticity (Spastic) 01/2019
1	Trisomy (Trisomies) 07/2018
1	type 2C Limb-girdle muscular dystrophy 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 12/2017
1	Diabetes Mellitus 01/2017
1	Wasting Syndrome (Wasting Disease) 01/2017
1	Protein Deficiency 03/2016
1	Cleft Palate (Palate, Cleft) 11/2015
1	Cleft Lip (Harelip) 11/2015

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2002
12	DystrophinIBA 01/2018 - 04/2008
4	CytokinesIBA 10/2021 - 01/2004
4	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 09/2003
4	Creatine Kinase (Creatine Phosphokinase)IBA 05/2015 - 01/2003
4	Muscle Proteins (Muscle Protein)IBA 11/2008 - 03/2003
3	AutoantibodiesIBA 01/2022 - 01/2021
3	EnzymesIBA 01/2022 - 01/2019
3	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 12/2020 - 05/2007
2	Interferon Type IIBA 01/2022 - 01/2021
2	Biological ProductsIBA 01/2022 - 01/2022
2	ChemokinesIBA 10/2021 - 01/2020
2	myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)IBA 01/2021 - 01/2019
2	Sarcoglycans (beta Sarcoglycan)IBA 01/2018 - 11/2008
2	CollagenIBA 01/2015 - 11/2008
2	SmokeIBA 01/2015 - 01/2015
2	CalpainIBA 11/2008 - 12/2002
2	DysferlinIBA 11/2008 - 09/2008
2	Monoamine Oxidase (MAO)IBA 06/2005 - 01/2005
2	Protein Isoforms (Isoforms)IBA 01/2004 - 03/2003
1	InterferonsIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	ChloridesIBA 11/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	micaIBA 01/2021
1	Coal Tar (Estar)IBA 01/2021
1	LipidsIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	FurinIBA 01/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021
1	Glycophorins (Glycophorin C)IBA 06/2020
1	Chemokine CCL5IBA 01/2020
1	5'-Nucleotidase (5' Nucleotidase)IBA 01/2019
1	dichlorobis(azomycin)platinum IIIBA 07/2018
1	Immunoglobulins (Immunoglobulin)IBA 12/2017
1	Immunoglobulin G (IgG)IBA 12/2017
1	Phospholipid Transfer ProteinsIBA 01/2017
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	UtrophinIBA 03/2016
1	Jagged-1 ProteinIBA 11/2015
1	Cadherins (E-Cadherin)IBA 11/2015

Therapy/Procedure

15	Therapeutics 10/2021 - 04/2007
5	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2016 - 09/2008
3	Transplantation 01/2021 - 07/2008
2	Injections 10/2021 - 01/2020
2	Low-Level Light Therapy (LLLT) 01/2015 - 01/2015
1	Liver Transplantation 02/2021
1	Spinal Injections 01/2020
1	Denervation 01/2019